SUPPLEMENTARY FIGURES
Supplementary Fig. S1 . Cholesterol-dependent membrane binding of PDZ domains with the CRAC motif. For all PDZ domains the black curve is for PM-mimetic vesicles (POPC/POPE/POPS/POPI/Cholesterol/PtdIns(4,5)P 2 = 12:35:22:8:22:1), the blue curve for PM-cholesterol vesicles (POPC/POPE/POPS/POPI/PtdIns(4,5)P 2 =23:46:22:8:1) and red one for PM-mimetic vesicles with a cholesterol derivative (POPC/POPE/POPS/POPI/5α,6β-dihydroxycholestanol/PtdIns(4,5)P 2 =12:35:22:8:22:1; labeled as PM'). Protein concentration used for the SPR measurement is shown for each PDZ domain. While 8 PDZ domains in the first two rows show clear cholesterol dependency in membrane binding, four PDZ domains in the bottom row do not. NHERF1-PDZ1 shows slow dissociation from the vesicle The binding isotherm was generated from the R eq (average of triplicate measurements) versus the concentration (P 0 ) of NHERF1-PDZ1 plot. A solid line represents a theoretical curve constructed from R max (= 75 ± 7) and K d (= 38 ± 9 nM) values determined by nonlinear least squares analysis of the isotherm using the following equation: R eq = R max /(1 + K d /P 0 ). (C) The binding isotherm for NHERF1-PDZ1 without C-terminal His 6 tag, which was generated by removing a N-terminal GST tag wit thrombin after purification by affinity chromatography. Notice that its K d (= 41 ± 4 nM) determined by curve fitting is essentially the same as the His 6 -tagged NHERF1-PDZ1. Equilibrium SPR measurements were performed in 20 mM Tris-HCl, pH 7.4, containing 0.16 M NaCl. , and K32A/K34A (red). 300 µg/ml proteins were dissolved in phosphate buffer, pH 7.4, and the averages of six consecutive scans were taken. Notice that three proteins have essentially the same spectra, showing that mutations did not cause deleterious structural changes. Since the estimated surface pressure of biological membranes is about 31 dyne/cm, the protein whose critical surface pressure is > 31 dyne/cm is considered to be able to penetrate the biological membranes. Thus, PS enables NHERF1-PDZ1 WT to penetrate cholesterol-containing membranes. Even in the presence of PS, L42A/V43A cannot penetrate cholesterol-containing membranes as effectively as WT. The effect of PS is not simply due to the increased surface concentration of PDZ domains because the monolayer measurements were done under the condition that saturating concentrations of proteins were employed in the subphase. Da by averaging signals from 3,000 consecutive laser shots with a frequency of 1,000 Hz. To enhance the spectral resolution, all spectra were measured in the reflector mode. MALDI spectra showed that extrusion of vesicles did not significantly change the relative intensities of the molecular ions of phospholipids. (B) Cholesterol contents of LUVs were separately assessed by gas chromatography-MS analysis. Integrated areas for cholesterol peaks before and after extrusion showed a modest decrease (≈18%).
Supplementary Fig. S14
Supplementary Fig. S14 . Effect of membrane extrusion on the vesicle incorporation of 5α,6β-dihydroxycholestanol. The concentration of 5α,6β-dihydroxycholestanol in LUVs before and after extrusion was assessed by gas chromatography-MS analysis as described in Fig. S13 . Integrated areas for 5α,6β-dihydroxycholestanol peaks before and after extrusion showed a modest decrease (≈27%) after extrusion, which is comparable to that seen with cholesterol (see Fig.  S13B ). This shows that 5α,6β-dihydroxycholestanol is incorporated into the extruded vesicles almost as well as cholesterol. 
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SUPPLEMENTARY METHODS
Materials
All lipids were purchased from Avanti Polar Lipids. The rabbit polyclonal antibody against NHERF1 was from Thermo Fisher Scientific. Horseradish peroxidaseconjugated goat anti-rabbit IgG was purchased from Cayman. The horseradish peroxidase conjugate substrate kit was from Bio-Rad. Forskolin, 3-isobutyl-1-methylxanthine, and bumetanide were from Sigma. 6-Methoxy-N-(3-sulfonropyl)quinolinium was from Molecular Probes.
Plasmid construction
The cDNAs for the full-length NHERF1 and its PDZ1 domain were subcloned into both pET21a (+) (Invitrogen) and pEGFPC1 (BD Clonetech) vectors for bacterial and mammalian cell expression, respectively. Constructs for other PDZ domains were also prepared using the pET21a (+) vector. The D domain (residue 391-500) of perfringolysin O that shows high specificity for cholesterol 1 was subcloned into the pGEX-4T-1 vector. Mutagenesis was performed using the QuickChange kit (Stratagene). All constructs were confirmed by DNA sequencing.
Protein expression and purification
The constructs for all PDZ domains containing a C-terminal His 6 tag were transformed into Escherichia coli BL21(DE3)pLys (Novagen) cells for protein expression. Expressed proteins were loaded onto the Ni-NTA agarose resin (Qiagen) and eluted with 50 mM Na 2 HPO 4 , pH 8.0, 300 mM NaCl containing 50-150 mM imidazole. Fractions were then pooled and the further purified on a Q-Sepharose ion-exchange column. The D domain of perfringolysin O was transformed into E. coli RIL cells and expressed as a glutathion-S-transferase-tagged protein. The protein was purified by affinity chromatography using the glutathione S-transferase-Tag TM resin (Novagen, Madison, WI). Protein concentration was then determined by the bicinchoninic acid method (Pierce). The proteins were stored at -80°C for further study.
Lipid vesicle preparation
PM-mimetic vesicles were prepared by mixing 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoserine (POPS), cholesterol, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoinositol (POPI), and 1,2-dipalmitoyl derivatives of PtdIns(4,5)P 2 in a molar ratio of 12:35:22:22:8:1. Large unilamellar vesicles with 100-nm diameter were prepared with a Liposofast (Avestin) microextruder using a 100-nm polycarbonate filter. Giant unilamellar vesicles (GUVs) were prepared by electroformation. The lipid mixture were prepared in chloroform/methanol (3:1) at a total concentration of 0.4 mg/ml, then the lipid solution was spread onto the indium-tin oxide electrode surface and the lipid was dried under vacuum to form a uniform lipid film. Vesicles were grown in a sucrose solution (350 mM) while an electric field (3V, 20Hz frequency) was applied for 5 hour at room temperature. After 1 to 2 µl of sucrose-loaded GUV solution was added into a well glued onto a coverslip that was placed on the microscope stage. The well contained 200 µl of 20 mM Tris-HCl buffer, pH 7.4, with 0.16 M KCl solution. The diameter of GUVs ranged from 5 to 30 µm.
Monolayer measurements
Surface pressure of solution in a circular Teflon trough (4 cm diameter x 1 cm deep) was measured using a Wilhelmy plate attached to a computer-controlled Cahn electrobalance (Model C-32) as described previously 2 . Five to ten µl of lipid solution (POPC/POPS/cholesterol = 6:2:2) in ethanol/hexane (1:9 (v/v)) was spread onto 10 ml of subphase (20 mM HEPES, pH 7.4, containing 0.16 M KCl) to form a monolayer with a given initial surface pressure. Once the surface pressure reading of monolayer stabilized, the protein solution (typically 40 µl) was injected into the subphase through a small hole drilled at an angle through the wall of the trough and the change in surface pressure was measured as a function of time with gentle stirring until it reached a maximal value. The maximal change in surface pressure value at a given initial surface pressure depended on the protein concentration and thus protein concentrations in the subphase were maintained high enough (typically ≥1 µg/ml) to ensure that the observed change in surface pressure represented a maximal value. The critical surface pressure was determined by extrapolating the change in surface pressure versus initial surface pressure plot to the x-axis 3 .
Determination of PDZ domain bound to GUV by fluorescence microscopy. All fluorescence microscopy measurements were carried out at 37 ºC using a custombuilt multi-photon microscope that was described previously4. Both instrument control and data analysis were performed by the SimFCS. GUV composed of POPC/POPS/cholesterol (80-x:20:x; x = 0-30 mole%) were mixed with 200 nM EGFPNHERF1-PDZ1 in 20 mM Tris-HCl, pH 7.4, containing 0.16 M NaCl. For each cholesterol concentration, 10 GUVs were selected and for each GUV, an averaged image of a total of 10 frames was collected for further analysis by MATLAB (MathWorks, Inc). The total photon counts in blue and green channels of the image were read into a M x N (typically 256 x 256) matrix: (I)i,j ( 0 ≤ I ≤ M -1 and 0 ≤ j≤ N -1) to recreate the averaged image. Each matrix element (one pixels, a i,j ) represents the raw photon counts. Then a binary image mask (I') was created on the lipid bilayer of GUV using this image matrix by analyzing the photon count histogram of the image. For any a' i,j ∈ I', either a' i,j =0 or a' i,j =1. So the result of element by element multiplication of I and I' (i.e., I''=I x I') will be a i,j x a' i,j = a i,j where a' i,j = 1 and a i.j x a' i,j = 0 where a' i,j = 0. The total photon counts of GUV (FB(total) and FG(total)) were divided by the total area of the pixels that constitute each GUV to yield the photon counts per area.
Binding to radiolabeled cholesterol
Binding of PDZ domains to 1,2-3 H-labeled cholesterol (Perkin-Elmer) was performed in 20 mM Tris-HCl, pH 7.4, with 160 mM NaCl and 1 µM of protein as reported previously 5 . Cholesterol in ethanol was added to the protein solution to a final concentration ranging from 0 to 10 µM and the mixture was incubated at 25 °C for 1 hour. A His SpinTrap column (GE Healthcare) was pre-equilibrated with 20 mM Tris-HCl pH 7.4 with 160 mM NaCl, and the reaction mixture was added to the column and incubated for 5 minutes. The column was washed three times by 600 µl of the same buffer, and the protein was eluted using 600 µl of 20 mM Tris-HCl pH 7.4 with 160 mM NaCl and 300 mM immidazole. 200 µl of the washed (free cholesterol) and eluted (protein-bound cholesterol) solutions were taken for radioactivity measurement using the Beckman LS6500 liquid scintillation counter.
GST pull-down experiment Glutathione S-transferase (GST) and GST-fusion CFTR peptides (GST-QDTRL) were expressed in BL21 (DE3) pLysS (Novagen) and purified. The proteins were mixed with glutathione beads in the incubation buffer (20 mM Tris-HCl, pH 7.4, 0.16 M NaCl, 1% Triton X-100) and the beads with the bound proteins were washed three times with the buffer and re-suspended in the buffer. Purified human recombinant NHERF1 proteins (0-5 µg) were incubated with 5 µg of GST and GST-CFTR bound to the beads for 30 min at 4˚C. The bound proteins were collected by brief centrifugation, washed 3 times with the incubation buffer, extracted with the Laemmli buffer, and subjected to dodecylsulfate-polyacrylamide gel electrophoresis and immunoblotting using the rabbit polyclonal antibody against NHERF1 and horseradish peroxidase-conjugated goat antirabbit IgG.
Measurement of Chloride Channel Activity of CFTR
Whole-cell and single channel recordings were performed in HEK293 cells expressing CFTR and/or various NHERF1 constructs using the protocols reported previously 6 with minor modifications. In whole-cell patch clamp, the pipette solution contained 140 mM N-methyl D-glucamine chloride (NMDG-Cl), 5mM EGTA, 1mM MgCl 2 , 1 mM Tris-ATP, and 10 mM HEPES (pH 7.4), and the bath solution contained 140 mM NMDG-Cl, 1 mM CaCl 2 , 1 mM MgCl 2 , 10 mM glucose, and 10 mM HEPES (pH 7.4). All experiments were performed at room temperature (22-25 °C). After establishing the whole-cell configuration, CFTR was activated by adding forskolin (5 µM). The current output was filtered at 5 kHz and currents were digitized and analyzed using AxoScope 10.2 system and Digidata 1322A analog/digital converter (Axon Instruments). The CFTR inhibitor CFTRinh-172 was purchased from Sigma-Aldrich. The authenticity of currents generated by CFTR was confirmed by current activation by cAMP generation, current inhibition by a CFTR inhibitor CFTRinh-172, and the linear current-voltage relationship (Fig. S10) . Single channel activity was measured in inside-out configurations using firepolished pipettes with a resistance of 20-25 megaohms. The pipette solution contained 146 mM N-methyl D-glucamine chloride (NMDG-Cl), 1 mM MgCl 2 , 1 mM CaCl 2 , and 10 mM HEPES (pH 7.4), and the bath solution contained 150 mM NMDG-Cl, 1 mM EGTA, and 10 mM HEPES (pH 7.4). Following patch excision, channels were activated by adding the catalytic subunit of protein kinase A (PKA) (20 unit/ml; Promega) and 3 mM MgATP. After channel activation, purified His-tagged NHERF1-wild type (WT) or NHERF1-Y38A/R40A protein (100 nM) was added to the bath. Holding voltage used in the single channel recording was -60 mV. The pCLAMP software package was used for data acquisition and analysis. The voltage and current data were low pass-filtered at 0.5 kHz during the recordings, and the single channel data were further digitally filtered at 25 Hz. It has been shown in excised patches that NHERF1 can directly upregulate CFTR Cl -channel function independently of its AKAP-recruiting scaffold activity 6 .
Confocal and Single Molecule Imaging
MDCK2 cell transiently transfected with N-terminal-enhanced green fluorescence protein (EGFP)-tagged NHERF1 were used for confocal imaging. Confocal imaging was performed using Zeiss LSM510 microscope. HEK 293 cells stably expressing the EGFP-CFTR was transfected with Halo TM (Promega)-tagged NHERF-1 and labeled with Halo-Tag tetramethylrhodamine (Promega) for TIRF imaging. The EGFP-tagged human CFTR in pcDNA3.1(-) (Invitrogen) was transfected into HEK293 cell with 1 µg DNA and 0.5 µl of Lipofactamine 2000 (Invitrogen) for each well of 8-well plate (Thermo Scientific). HEK 293 cells stably expressing the EGFP-CFTR was prepared after selection with 1 mg/ml geneticin (Gibco) for 2 weeks and maintained with 200 µg/ml of geneticin. After a few passages, the stable cell line was transfected with 0.05 µg of Halo TM (Promega)-tagged NHERF-1 and 0.3 µl of Lipofactamine 2000 for each well of 8-well plate for 4 hours and kept at 37 o C in a 5% CO 2 incubator for 12 hours. As a control, one plate was treated only with Lipofactamine 2000. Halo-Tag tetramethylrhodamine (TMR, Promega) diluted 200,000 times with the media was added to each well for labeling Halo-NHERF1 and the plates were kept at 37 o C in a 5% CO 2 incubator for 15 min. The TMR-containing media were replaced by equal amount of warm fresh media and after 3x washing, the plates were kept at 37 o C for 30 min. Finally, the media was replaced with one without phenol red for imaging. An Olympus IX71 microscope was used as the base for the custom-built TIRF microscope. For dual color imaging, two DPSS lasers (488/561 nm, Excelsior, Spectra-Physics) were introduced to an Olympus 100x TIRF oil-immersion objective (numerical aperture 1.49) through the side port parallel but off the optical axis using a dual band dichroic mirror (XF2044 490-575DBDR, Omega Optical). The fluorescence from the sample was split into two channels through a dichroic mirror (565DCXR Chroma) and passed through emission filters (510BP20, Omega and D630/30, Chroma) and finally projected on to the EM-CCD cameras (Andor) acquiring images of 512x512 at 30 msec interval. The images were spatially corrected following the algorithm described previously 7 . Briefly, the centroids of an array of holes spaced 5 µm on a grid were used to create a lookup table for each channel using a cubic spline interpolation for the correction of the raw images through the remapping of the pixel intensities based on the lookup tables. All particle tracking, data analysis and image processing were carried out with in-house programs written in MATLAB.
Structural modeling of CFTR and Electrostatic calculation
A structure model of the C-terminal domain of CFTR was constructed using our structure prediction tool RaptorX 8 . First, domain parsing of the CFTR protein sequence (P13569) was done to determine the individual folding units of the full protein sequence. From this analysis it was determined that CFTR is composed of a total of 14 domains, with the residues 1423 to 1480 constituting the C-terminal folding unit containing the PDZ binding peptide. Since protein domains are known to act as independent functional units, further analysis focused exclusively on the C-terminal domain (referred to as CFTR-14 hereafter). A series of structure models was constructed for CFTR-14 based on a multiple sequence alignment with template structures, 1R5I-D and 3KPH-A. The top-ranked structure model used further in this study had a quality score of 54 (a model scoring 30 or higher is normally considered reliable). To better gauge the full interaction context of CFTR-14 with NHERF1-PDZ1, the newly constructed structure of CFTR-14
